NASA's Artemis program aims to use the Moon as a stepping stone for human exploration of Mars. Artemis II, scheduled for 2026, will be the first crewed mission of the program, orbiting the Earth ...

KENNEDY SPACE CENTER — On Friday, NASA unveiled the massive Artemis II rocket that will be used to return humans to the moon in an orbital mission that will last 10 days as the program manager ...

March 7 (UPI) --NASA on Friday rolled out the new Artemis II Orion spacecraft and twin Space Launch System solid rocket boosters that will carry astronauts in the first crewed Artemis mission ...

NASA is seeking submissions for a new zero gravity indicator (ZGI) that will accompany the Artemis II astronauts on their upcoming trip around the moon. But if you think you need an advanced ...

WESH 2’S MEGAN MORIARTY GOT AN UP CLOSE LOOK AT THE BIG PIECES OF THE ARTEMIS TWO MISSION. AS WE WAIT TO HEAR SPACEX’S NEXT MOVE. AFTER LAST NIGHT’S MISHAP. NASA’S ARTEMIS PROGRAM IS ...

KENNEDY SPACE CENTER — There’s a sense of urgency among NASA and its partners aiming for the first human spaceflight of the Artemis program. Artemis II is slated to launch four astronauts on ...

A new study from Mass General Brigham researchers has found faster accumulation of tau-a key indicator of Alzheimer's disease-in the brains of women over the age of 70 who took menopausal hormone ...

Residents in Fifth Ward in Kashmere Gardens got an update on the soil samples taken from a cancer cluster at the site of the former Union Pacific Railroad, once owned by Southern Pacific.

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...